As an innovative, strategic partner company, Haselmeier develops and produces customised, unique systems that are...
The Haselmeier Group has decided to reinforce and reorganise its Executive Board.
Mr Gert Weber has been nominated by the board of directors of Medico Invest AG as CEO of the Haselmeier Group. This nomination is effective starting 1 July 2015.
Mr Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions.
His last position was managing director and vice-president responsible for Operations and Information Technology (IT) at Avnet TS, which used to be Magirus Group.
With his experience and expertise, Mr Weber shall contribute to strengthen Haselmeier’s position and performance in the medical device industry.
Mr Weber joined Haselmeier as chief information officer on 1 May 2015, and will continue to lead Haselmeier’s efforts to build up efficient organisation and state-of-the-art IT.
Haselmeier is committed to position IT as a strategic growth driver for its operations, as well as an opportunity to develop new business areas.
Mr Andreas Schieber leaves Haselmeier, starting 30 June 2015. Mr Schieber, as interim chairman of the Executive Board, actively contributed to the structuring and installation of Haselmeier’s Group Management.
Haselmeier offers clarity to its quality organisation and establishes two subgroups covering respectively quality management and assurance, with dedicated teams and leadership.
Both groups will report to Mr Matthias Meissner who has endorsed the function of chief quality officer, effective since 1 July 2015 on an interim basis.
Mr Meissner replaces Mr Markus Dorsch who contributed to build Haselmeier’s quality management over the past ten years. Mr Meissner has been instrumental in the development of Haselmeier’s infrastructure and the installation of efficient manufacturing capabilities and shall support the installation of a global quality management.
Mr Siegfried Eichinger has been appointed chief financial officer (CFO), effective since 1 July 2015. In his extended CFO role, Mr Eichinger will lead Haselmeier’s global finance and controlling and will be responsible for the Group’s Human Resources Management.
Mr Eichinger brings more than 20 years of experience in the technological and healthcare industries and shall ensure Haselmeier co-ordinated planning, development and management of its resources on a group-wide basis.
With the reinforcement of its Executive Board, Haselmeier demonstrates its commitment for a sustainable development towards high performance, breakthrough innovations and excellent service for its customers.
The D-Flex injection pen can do more than previous pens. D-Flex can be configured for...
Type 2 diabetes is a global health problem. According to expert estimates, the number of...
Haselmeier has announced it will be developing a smart connected monitoring and support solution in...